{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:51:23Z","timestamp":1780987883674,"version":"3.54.1"},"reference-count":50,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1111\/trf.14168","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T20:35:50Z","timestamp":1496867750000},"page":"1599-1624","source":"Crossref","is-referenced-by-count":74,"title":["Supplemental findings from the National Blood Collection and Utilization Surveys, 2013 and 2015"],"prefix":"10.1111","volume":"57","author":[{"given":"Mathew R.P.","family":"Sapiano","sequence":"first","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"},{"name":"Surveillance Branch, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra A.","family":"Savinkina","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"},{"name":"Oak Ridge Institute for Science and Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Ellingson","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"},{"name":"The University of Arizona College of Public Health Tucson Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Haass","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha L.","family":"Baker","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"},{"name":"Northrop Grumman Corporation Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Henry","sequence":"additional","affiliation":[{"name":"Office of HIV\/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, U.S. Department of Health & Human Services Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Berger","sequence":"additional","affiliation":[{"name":"Office of HIV\/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, U.S. Department of Health & Human Services Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Kuehnert","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[{"name":"Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13644"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","unstructured":"EllingsonKD SapianoMRP HaassKA et al. Continued Decline in Blood Collection and Transfusion in the United States \u2013 2015; Transfusion.2017. (In Press).","DOI":"10.1111\/trf.14165"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00203.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03288.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01128.x"},{"key":"e_1_2_10_7_1","unstructured":"The 2011 National Blood Collection and Utilization Survey Report. Washington (DC): US Department of Health and Human Services;2013."},{"key":"e_1_2_10_8_1","unstructured":"Recommendations of the 48th ACBTSA Meeting November 28\u201029 2015. Washington (DC): U.S. Department of Health and Human Services; 2015."},{"key":"e_1_2_10_9_1","unstructured":"Blood establishment registration and product listing [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2017 [cited 2017 Feb 27]. Available from:https:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/EstablishmentRegistration\/BloodEstablishmentRegistration\/default.htm."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1198\/000313006X126819"},{"key":"e_1_2_10_11_1","volume-title":"Multiple imputation for nonresponse in surveys","author":"Rubin DB.","year":"2004"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1971.10482279"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4377-0974-2.00030-0"},{"key":"e_1_2_10_14_1","unstructured":"Prothrombin time test [Internet]. Rochester (MN):Mayo Clinic; c1998\u20102017 [cited January 16 2017]. Available from:http:\/\/www.mayoclinic.org\/tests-procedures\/prothrombin-time\/details\/results\/rsc-20163828."},{"key":"e_1_2_10_15_1","unstructured":"Normal lab values [Internet]. San Francisco:University of California San Francisco; yyyy [cited January 16 2017]. Available from:http:\/\/missinglink.ucsf.edu\/lm\/ids_106_lowergi\/lower%20gi\/mainpages\/normallabvalues.htm."},{"key":"e_1_2_10_16_1","volume-title":"Hematology: basic principles and practice","author":"Schmaier AH","year":"2012"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60673-X"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011311"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.01.003"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360035027"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.2.229"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01517.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00593.x"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39399219291.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.19.2279"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310450030018"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02865.x"},{"key":"e_1_2_10_28_1","unstructured":"Blood Products Advisory Committee. Topic IA. Considerations for iron management in blood donors. Silver Spring (MD): U.S. Food and Drug Administration;2016."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02288.x"},{"key":"e_1_2_10_30_1","unstructured":"Blood Products Advisory Committee. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Silver Spring (MD): U.S. Food and Drug Administration;2016."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530740-000000000-00000"},{"key":"e_1_2_10_32_1","volume-title":"Towards a sustainable blood supply in the United States","author":"Mulcahy A","year":"2016"},{"key":"e_1_2_10_33_1","unstructured":"Fatalities reported to FDA following blood collection and transfusion (FY2015) [Internet]. Silver Spring (MD): U.S. Food and Drug Administration Center for Biologics Evaluation and Research;2015[cited January 16 2017]. Available from:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/SafetyAvailability\/ReportaProblem\/TransfusionDonationFatalities\/UCM518148.pdf."},{"key":"e_1_2_10_34_1","unstructured":"National Healthcare Safety Network biovigilance component hemovigilance module surveillance protocol [Internet]. Atlanta:Centers for Disease Control and Prevention;2017[cited 2017 Jan 30]. Available from:https:\/\/www.cdc.gov\/nhsn\/PDFs\/Biovigilance\/BV-HV-protocol-current.pdf."},{"key":"e_1_2_10_35_1","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1802.101219"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04347.x"},{"key":"e_1_2_10_38_1","unstructured":"International Society of Blood Transfusion Working Party on Haemovigilance. Transfusion\u2010associated circulatory overload (TACO): draft revised reporting criteria [Internet]. Bethesda: AABB;2016[cited 2017 Jan 31]. Available from:https:\/\/www.aabb.org\/research\/hemovigilance\/Documents\/TACO-reporting-criteria-draft-Nov-2016.pdf."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12262"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12918"},{"key":"e_1_2_10_41_1","unstructured":"BasavarajuSV HaassKA SapianoMRP KuehnertMJ. Transfusion\u2010related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module United States 2013 to 2015. ISBT Conference Abstract; 2016."},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32192116426.x"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00905.x"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01811.x"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12323"},{"key":"e_1_2_10_46_1","unstructured":"AABB donor hemovigilance report [Internet]. Bethesda: AABB;2012[cited January 8 2017]. Available from:http:\/\/www.aabb.org\/research\/hemovigilance\/Documents\/aabb-donor-hemovigilance-report-2012.pdf."},{"key":"e_1_2_10_47_1","unstructured":"DonorHART donor hemovigilance analysis & reporting tool: user manual 2.0 [Internet]. Bethesda: AABB;2014[cited January 8 2017].http:\/\/www.aabb.org\/research\/hemovigilance\/Documents\/biovigilancemanual.pdf."},{"key":"e_1_2_10_48_1","unstructured":"RajbhandaryS StubsJR LandKJ et al.AABB donor hemovigilance report: 2012\u20102014 on behalf of the AABB US Donor Hemovigilance Working Group. Bethesda: AABB;2016."},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.12.002"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2014.08.003"},{"key":"e_1_2_10_51_1","unstructured":"Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of PLTs for transfusion. Silver Spring (MD): US Food and Drug Administration Center for Biologics Evaluation and Research;2016."}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.14168","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T23:05:39Z","timestamp":1694473539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.14168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1111\/trf.14168"],"URL":"https:\/\/doi.org\/10.1111\/trf.14168","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}